| [1] |
Alkharfy TM, Ba-Abbad R, Hadi A, et al. Total parenteral nutrition-associated cholestasis and risk factors in preterm infants[J]. Saudi J Gastroenterol, 2014, 20(5): 293-296.
|
| [2] |
Christensen RD, Henry E, Wiedmeier SE, et al. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease[J]. J Perinatol, 2007, 27(5): 284-290.
|
| [3] |
杨军，李水霞，陈莉娜. 极低出生体质量儿胃肠外营养相关性胆汁淤积危险因素临床分析[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(5): 559-563.
|
| [4] |
Lee SM, Namgung R, Park MS, et al. Parenteral nutrition associated cholestasis is earlier, more prolonged and severe in small for gestational age compared with appropriate for gestational age very low birth weight infants[J]. Yonsei Med J, 2013, 54(4): 839-844.
|
| [5] |
Kim AY, Lim RK, Han YM, et al. Parenteral nutrition-associated cholestasis in very low birth weight infants: a single center experience[J]. Pediatr Gastroenterol Hepatol Nutr, 2016, 19(1): 61-70.
|
| [6] |
Sharef SW, Al-Sinani S, Al-Naamani K, et al. Incidence and risk factors of parenteral nutrition-associated cholestasis in omani neonates single centre experience[J]. Sultan Qaboos Univ Med J, 2015, 15(2): e234-e240.
|
| [7] |
Lauriti G, Zani A, Aufieri R, et al. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review[J]. JPEN J Parenter Enteral Nutr, 2014, 38(1): 70-85.
|
| [8] |
Lee HH, Jung JM, Nam SH, et al. Risk factor analysis of parenteral nutrition-associated cholestasis in extremely low birth weight infants[J]. Acta Paediatr, 2016, 105(7): e313-e319.
|
| [9] |
Xu Z, Harvey KA, Pavlina T, et al. Steroidal compounds in commercial parenteral lipid emulsions[J]. Nutrients, 2012, 4(8): 904-921.
|
| [10] |
El Kasmi KC, Anderson AL, Devereaux MW, et al. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease[J]. Sci Transl Med, 2013, 5(206): 206ra137.
|
| [11] |
Fallon EM, Le HD, Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil[J]. Curr Opin Organ Transplant, 2010, 15(3): 334-340.
|
| [12] |
Gupta K, Wang H, Amin SB. Parenteral nutrition-associated cholestasis in premature infants: role of macronutrients[J]. JPEN J Parenter Enteral Nutr, 2016, 40(3): 335-341.
|
| [13] |
Jakobsen MS, Jørgensen MH, Husby S, et al. Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants[J]. Dig Dis Sci, 2015, 60(1): 252-259.
|
| [14] |
贝斐，孙建华，叶秀霞，等. 早期应用氨基酸对极低出生体重儿胃肠外营养相关性胆汁淤积的影响[J]. 中国新生儿科杂志，2011, 26(2): 83-86.
|
| [15] |
Spencer AU, Yu S, Tracy TF, et al. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine[J]. JPEN J Parenter Enteral Nutr, 2005, 29(5): 337-344.
|
| [16] |
Fok TF, Chui KK, Cheung R, et al. Manganese intake and cholestatic jaundice in neonates receiving parenteral nutrition: a randomized controlled study[J]. Acta Paediatr, 2001, 90(9): 1009-1015.
|
| [17] |
Blaszyk H, Wild PJ, Oliveira A, et al. Hepatic copper in patients receiving long-term total parenteral nutrition[J]. J Clin Gastroenterol, 2005, 39(4): 318-320.
|
| [18] |
Alemmari A, Miller GG, Bertolo RF, et al. Reduced aluminum contamination decreases parenteral nutrition associated liver injury[J]. J Pediatr Surg, 2012, 47(5): 889-894.
|
| [19] |
El Kasmi KC, Anderson AL, Devereaux MW, et al. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury[J]. Hepatology, 2012, 55(5): 1518-1528.
|
| [20] |
Yang XF, Liu GS, Li MX. Analysis of mutations of MDR3 exons 9 and 23 in infants with parenteral nutrition-associated cholestasis[J]. Exp Ther Med, 2015, 10(6): 2361-2365.
|
| [21] |
Yang XF, Liu GS, Yi B. Correlation between mutation of MDR3 gene exon 6 and parenteral nutrition-associated cholestasis of preterm infants[J]. Exp Ther Med, 2014, 8(5): 1655-1659.
|
| [22] |
Best CM, Gourley GR, Bhutani VK. Neonatal cholestasis-conjugated hyperbilirubinemia//Buonocore G. Neonatology: a practical approach to neonatal diseases[M]. Milan (Italy): Springer, 2012: 650-658.
|
| [23] |
Chen CY, Tsao PN, Chen HL, et al. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis[J]. J Pediatr, 2004, 145(3): 317-321.
|
| [24] |
Satrom K, Gourley G. Cholestasis in preterm infants[J]. Clin Perinatol, 2016, 43(2): 355-373.
|
| [25] |
Dani C, Pratesi S, Raimondi F, et al. Italian guidelines for the management and treatment of neonatal cholestasis[J]. Ital J Pediatr, 2015, 41(1): 69-80.
|
| [26] |
D′Apolito O, Pianese P, Salvia G, et al. Plasma levels of conjugated bile acids in newborns after a short period of parenteral nutrition[J]. JPEN J Parenter Enteral Nutr, 2010, 34(5): 538-541.
|
| [27] |
Simić D, Milojević I, Bogićević D, et al. Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants[J]. Srp Arh Celok Lek, 2014, 142(3-4): 184-188.
|
| [28] |
Thibault M, McMahon J, Faubert G, et al. Parenteral nutrition-associated liver disease: a retrospective study of ursodeoxycholic acid use in neonates[J]. J Pediatr Pharmacol Ther, 2014, 19(1): 42-48.
|
| [29] |
祝华平，夏世文. 还原型谷胱甘肽预防极低出生体重儿胃肠外营养相关性胆汁淤积[J]. 中国新生儿科杂志，2010, 25(5): 275-277.
|
| [30] |
Salvador A, Janeczko M, Porat R, et al. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants[J]. J Pediatr, 2012, 161(2): 229-233.
|
| [31] |
Burns DL, Gill BM. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (omegaven) in an adult dependent on home parenteral nutrition[J]. JPEN J Parenter Enteral Nutr, 2013, 37(2): 274-280.
|
| [32] |
Colomb V, Dabbas-Tyan M, Taupin P, et al. Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients[J]. J Pediatr Gastroenterol Nutr, 2007, 44(3): 347-353.
|
| [33] |
Leaf A, Dorling J, Kempley S, et al. Early or delayed enteral feeding for preterm growth-restricted infants: a randomized trial[J]. Pediatrics, 2012, 129(5): e1260-e1268.
|
| [34] |
蔡威，汤庆雅，王莹，等. 中国新生儿营养支持临床应用指南[J]. 临床儿科杂志，2013, 31(12): 1177-1182.
|
| [35] |
Clark RH, Chace DH, Spitzer AR, et al. Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial[J]. Pediatrics, 2007, 120(6): 1286-1296.
|
| [36] |
Cober MP, Killu G, Brattain A, et al. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease[J]. J Pediatr, 2012, 160(3): 421-427.
|
| [37] |
Rangel SJ, Calkins CM, Cowles RA, et al. Parenteral nutrition-associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee Systematic review[J]. J Pediatr Surg, 2012, 47(1): 225-240.
|
| [38] |
Park HW, Lee NM, Kim JH, et al. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and Meta-analysis[J]. J Nutr, 2015, 145(2): 277-283.
|
| [39] |
Lam HS, Tam YH, Poon TC, et al. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis[J]. Neonatology, 2014, 105(4): 290-296.
|
| [40] |
吴燕君，包蕾，华子瑜. 联合应用BB-12和LGG对极低出生体重早产儿胃肠功能的影响[J]. 中国微生态学杂志，2013, 25(3): 317-320.
|